Unilever Pakistan Foods Limited (PSX:UPFL)

Verve Therapeutics Balance Sheet

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,158	4,515	9,649	2,582	3,298	929.9
Short-Term Investments	-	-	-	2,692	-	-
Trading Asset Securities	6,687	6,642	3,810	3,080	-	-
Cash & Short-Term Investments	12,845	11,157	13,459	8,353	3,298	929.9
Cash Growth	-7.28%	-17.10%	61.12%	153.31%	254.64%	28.34%
Accounts Receivable	1,678	972.94	1,119	1,030	519.37	455.21
Other Receivables	2,137	2,778	3,755	1,532	775.41	915.32
Receivables	3,828	3,751	4,874	2,562	1,297	1,373
Inventory	3,714	3,489	4,517	3,116	1,524	1,163
Prepaid Expenses	-	80	72.94	36.53	50.23	28.66
Other Current Assets	115.46	84.33	184.07	237.65	33.51	119.39
Total Current Assets	20,503	18,562	23,106	14,306	6,203	3,615
Property, Plant & Equipment	9,012	9,342	7,869	6,227	4,101	3,745
Other Intangible Assets	81.64	81.64	81.64	81.64	81.64	81.64
Other Long-Term Assets	2.98	2.98	2.98	2.98	2.98	2.98
Total Assets	29,599	27,988	31,060	20,617	10,389	7,447
Accounts Payable	12,360	2,821	3,756	2,371	1,332	932.47
Accrued Expenses	200.64	7,458	7,306	5,892	3,058	2,586
Short-Term Debt	-	1,313	1,418	1,179	841.12	587.12
Current Portion of Long-Term Debt	124.61	124.61	74.36	21.37	-	-
Current Portion of Leases	-	-	-	22.25	0.39	11.52
Current Unearned Revenue	61.97	309.21	206.61	184.44	135.72	102.65
Other Current Liabilities	57.88	838.82	1,199	2,253	1,461	69.48
Total Current Liabilities	12,805	12,865	13,961	11,922	6,828	4,289
Long-Term Debt	483.95	496.09	557.87	491.12	168.62	23.66
Long-Term Leases	-	-	-	-	20.57	0.39
Long-Term Unearned Revenue	226.73	241.56	304.68	223.78	29.27	-
Long-Term Deferred Tax Liabilities	960.91	940.27	509.42	412.72	357.7	361.05
Total Liabilities	14,546	14,608	15,400	13,103	7,419	4,700
Common Stock	63.7	63.7	63.7	63.7	63.7	63.7
Additional Paid-In Capital	1,296	1,296	1,296	1,296	1,296	1,296
Retained Earnings	13,692	12,020	14,299	6,153	1,609	1,387
Comprehensive Income & Other	0.63	0.63	0.63	0.63	0.63	0.63
Shareholders' Equity	15,053	13,380	15,660	7,514	2,970	2,748
Total Liabilities & Equity	29,599	27,988	31,060	20,617	10,389	7,447
Total Debt	608.56	1,934	2,051	1,713	1,031	622.69
Net Cash (Debt)	12,236	9,224	11,408	6,640	2,267	307.21
Net Cash Growth	-7.42%	-19.15%	71.80%	192.90%	637.96%	238.17%
Net Cash Per Share	1920.88	1447.97	1790.89	1042.41	355.90	48.23
Filing Date Shares Outstanding	6.37	6.37	6.37	6.37	6.37	6.37
Total Common Shares Outstanding	6.37	6.37	6.37	6.37	6.37	6.37
Working Capital	7,698	5,696	9,146	2,383	-625.02	-674.17
Book Value Per Share	2363.12	2100.55	2458.31	1179.61	466.18	431.35
Tangible Book Value	14,972	13,299	15,578	7,432	2,888	2,666
Tangible Book Value Per Share	2350.30	2087.74	2445.49	1166.79	453.37	418.54
Land	-	8.18	8.18	8.18	8.18	8.18
Buildings	-	2,383	1,494	1,107	1,118	1,298
Machinery	-	7,928	4,658	2,690	2,354	3,795
Construction In Progress	-	1,666	4,082	2,568	673.92	201.55
Leasehold Improvements	-	14.92	14.92	-	-	14.92

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.